Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol. Issue 10 (October 2015)

• Record Type: Journal Article
• Authors: Honeyball, F.; Murali‐Ganesh, R.; Hruby, G.; Grimison, P.
• Is Part Of: Internal medicine journal. Volume 45:Issue 10(2015)
• Page Start: 1081
• Page End: 1084
• Publication Date: 2015-10
• Subjects: Medicine -- Periodicals; 616
• DOI: 10.1111/imj.12881
• Languages: English
• ISSNs: 1444-0903

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <p>The aim of this retrospective study was to determine the rate of compliance among 57 males with stage 1 testicular germ cell tumours on an active surveillance protocol at a single Australian centre. At median follow up of 24 months, 81% had adequate compliance with the follow‐up regimen, 12% were lost to follow up, and 16% relapsed; none between protocol visits. Active surveillance is an acceptable alternative to adjuvant therapy for stage 1 testicular germ cell tumours, with reduced toxicity for most and equivalent survival, but requires efforts to maintain adequate compliance with follow up to avoid late detection of recurrence.</p> </abstract>